Home › Epilepsy › Texas › Dallas
Epilepsy clinical trials in Dallas, TX
6 studies for Epilepsy are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
RecruitingPhase 3
- UT Southwestern Medical Center, Dallas
Diagnosing Epilepsy To EffeCT Change
Recruiting
- UT Southwestern Medical Center, Dallas
Pediatric Epilepsy
Recruiting
- Children's Medical Center Dallas, Dallas
Pharmacological Modulation of Brain Oscillations in Memory Processing
RecruitingEarly phase 1Healthy volunteers welcome
- University of Texas Southwestern Medical Center, Dallas
Prospective Natural History Study of POLG Disease
RecruitingObservational study
- Baylor Hospital, Dallas
Epilepsy Learning Healthcare System (ELHS)
RecruitingObservational study
- UT Southwestern Children's Dallas, Dallas
About Epilepsy
Epilepsy is a brain disorder that causes people to have seizures. The seizures may be mild or severe. Learn about causes, diagnosis, and treatment.
More about Epilepsy on MedlinePlus
Epilepsy trials in other cities
- Boston, MA18 studies
- Houston, TX15 studies
- New York City, NY14 studies
- Washington, DC13 studies
- Philadelphia, PA12 studies
- Durham, NC9 studies
- Phoenix, AZ9 studies
- Rochester, MN9 studies
- Cleveland, OH9 studies
- Miami, FL8 studies
- Birmingham, AL7 studies
- Mountain View, CA6 studies
Other studies in Dallas
- Breast Cancer54 studies
- Non-Small Cell Lung Cancer53 studies
- Metastatic Cancer44 studies
- Heart Failure42 studies
- Cancer (all types)40 studies
- Prostate Cancer39 studies
- Colorectal Cancer34 studies
- Obesity33 studies
- Ovarian Cancer31 studies
- Bladder Cancer27 studies
- Lung Cancer26 studies
- Endometrial Cancer25 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.